All
- All
- Product Management
- News
- Introduction
- Enterprise outlets
- FAQ
- Enterprise Video
- Enterprise Atlas
language
13
2021
-
04
In the spring breeze, we gathered at Chaohu, and the 2021 Biopharmaceutical Industry Development Forum was a complete success.
Source:
With the gentle spring breeze and the earth rejuvenating, from April 9 to 10, 2021, the "Opportunities for the Industrialization of New Biopharmaceuticals in the Post-Pandemic Era and the 2021 Biopharmaceutical Industry Development Forum" was grandly held in beautiful Chaohu, Anhui, organized by the Anhui Chaohu Biological Industry Park, Beijing Tianhe Yingtai Investment Management Co., Ltd., Beijing Xichuang Investment Management Co., Ltd., and Baolan Property Co., Ltd. Mr. Sun Luning, Chairman of Anhui Weiming, Mr. Yang Yong, General Manager of Tianhe Yingtai, Mr. Qin Jun, Director of the Beijing Protein Engineering Center, Mr. Zhu Xiaoqing, CEO of Mukang Ruichuang, Mr. Sheng Jingwei, CEO of Kunmai Medical, and representatives from many well-known investment institutions attended the forum, joining nearly three hundred guests on-site to explore the new future of the biopharmaceutical industry in the new era!
Integrate industry resources, support the development of pharmaceutical enterprises, and attract talent.
Mr. Sun Luning, Chairman of Anhui Weiming Biopharmaceutical Co., Ltd., introduced the positioning and development direction of the industrial park to the guests at the forum, as well as the comprehensive services and support provided to biopharmaceutical enterprises. He mentioned that the Bantang area of Chaohu, Anhui, integrates health care and tourism, combined with high-tech, high value-added, low pollution, and intensive biopharmaceutical enterprises, which embodies the "golden mountain and silver mountain" concept proposed by General Secretary Xi. The addition of new controlling shareholders will further help the industrial park integrate industry resources and provide comprehensive support for the development of enterprises in the park from financial investment, policy consulting, talent empowerment, and business docking, helping enterprises truly thrive in the Chaohu Economic Development Zone under government policy support.
Support high-tech enterprises, discuss the future of the industry.
Mr. Yang Yong, General Manager of Beijing Tianhe Yingtai Investment Management Co., Ltd., delivered the opening speech for the forum. He stated that Tianhe Yingtai and Xichuang Investment represent a wide range of investors, investing in the Anhui Chaohu Biological Industry Park and becoming new controlling shareholders, aiming to respond to the national call for financial support for the development of high-tech enterprises, with the goal of assisting and serving more domestic high-tech enterprises, seizing major opportunities in global biopharmaceutical development, gathering technical talents, and vigorously developing strategic emerging industries such as biopharmaceuticals. The Anhui Chaohu Biological Industry Park serves as a carrier and platform for innovative companies in the biopharmaceutical field. The purpose of holding this forum is also to provide opportunities for communication and cooperation among various enterprises in the biopharmaceutical industry, promoting the common development of biopharmaceutical enterprises.
Engage in dialogue with experts, step into the forefront of science.
This forum invited three industry experts and special guests, namely Mr. Qin Jun, Director of the Beijing Protein Engineering Center, Mr. Zhu Xiaoqing, CEO of Mukang Ruichuang Biopharmaceutical Technology, and Mr. Sheng Jingwei, CEO of Kunmai Medical Technology. The three experts and special guests delivered keynote speeches on "Innovation Leading the Development of Proteomics," "The Glamorous Transformation from Compounds to Drugs: An Introduction to Drug Development," and "The Development and Prospects of Brain Magnet Detection Technology," unraveling the secrets of the development of the biopharmaceutical industry from a professional perspective, stepping into the forefront of science, and understanding the latest research achievements, applications, and future research directions in the biopharmaceutical industry.
Achieve strategic cooperation, work hand in hand, and create the future together.
During this forum, Yiyang Group Co., Ltd. and Anhui Weiming Biopharmaceutical Co., Ltd. reached a strategic cooperation agreement. As a high-tech enterprise, Yiyang Group has vigorously developed the health industry in recent years, investing in overseas biotechnology. They have established a long-term, stable, comprehensive, and in-depth strategic cooperation relationship with the Anhui Chaohu Biological Industry Park under Anhui Weiming, fully leveraging each other's advantages in industry and park management, promoting the extension and development of both parties' businesses, and providing precise matching services and resource support for enterprises in the park.
On-site experience, communication and discussion, achieving cooperation.
The beautiful spring scenery brings warmth. During this forum, the organizers invited the guests to visit the Anhui Chaohu Industrial Park, arranging professional guides to introduce the park to the guests, allowing them to gain an in-depth understanding of the park's layout and landscape, and to experience the feeling of being in the park.
Communication and cooperation are the keywords of this forum. The representatives of the participating enterprises also introduced and recommended their companies to the financial investment institutions present, providing a comprehensive introduction to the company's history, core advantages, and technological achievements, hoping to gain more support and cooperation opportunities.
At this forum, the organizers specially invited leaders from the local management committee to attend and introduced the policy support and assistance provided by the local government to enterprises in the park, including rent discounts, tax policies, and project construction.
With the successful conclusion of the 2021 Biopharmaceutical Industry Development Forum, the enterprise investment and settlement in the Anhui Chaohu Industrial Park has begun. Through in-depth cooperation with new controlling shareholders and strategic partners, it is believed that in the future, the Anhui Chaohu Industrial Park will combine its own park advantages and industry resources with more excellent enterprises in the biopharmaceutical industry, working together to create a better future! Attracting talent and expecting more excellent enterprises to join and settle!
Key words:
In the future digital transformation of the pharmaceutical industry, how should pharmaceutical companies position themselves
2021-04-13
The current status of the development of the pharmaceutical industry in China in 2020.
2019 was an important year for the transformation and key upgrade of the pharmaceutical industry in our country.
2021-04-13
Progress has been made in the research of nano-medicines for pancreatic cancer.
Pancreatic cancer has a high mortality rate, and its fundamental reason for being difficult to treat lies in the fact
2021-04-13
Nanfang Daily News - On April 9, the fifth Cloud Cheng Tian Yu Food and Drug Review and Certification
2021-04-13
Contact
565 Tu Shan Road, Nan 'an District, Chongqing
Tel: 86-023-62505956
E-mail: cpri@cpri.com.cn
Tel: 86-023-62505956
E-mail: cpri@cpri.com.cn
Scan mobile websites
